Echinatin induces reactive oxygen species‐mediated apoptosis via JNK /p38 MAPK signaling pathway in colorectal cancer cells

Cancer statistics, 2022

(2022) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

YTHDF3 Facilitates eIF2AK2 and eIF3A Recruitment on mRNAs to Regulate Translational Processes in Oxaliplatin-Resistant Colorectal Cancer

(2022) Yang Zhao et al.   ACS Chemical Biology

Cardioprotective Effect of Echinatin Against Ischemia/Reperfusion Injury: Involvement of Hippo/Yes-Associated Protein Signaling

(2021) Jieting Niu et al.   Frontiers in Pharmacology

The tyrosine phosphatase SHP2 promotes proliferation and oxaliplatin resistance of colon cancer cells through AKT and ERK

(2021) Mengchao Yu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Oxaliplatin resistance in colorectal cancer enhances TRAIL sensitivity via death receptor 4 upregulation and lipid raft localization

(2021) Joshua D Greenlee et al.   eLife

Artemether, Artesunate, Arteannuin B, Echinatin, Licochalcone B and Andrographolide Effectively Inhibit SARS-CoV-2 and Related Viruses In Vitro

(2021) Yunjia Hu et al.   Frontiers in Cellular and Infection Microbiology

Sanguinarine impairs lysosomal function and induces ROS-dependent mitophagy and apoptosis in human hepatocellular carcinoma cells

(2021) Jingjing Wang et al.   ARCHIVES OF PHARMACAL RESEARCH

Kaempferol sensitizes cell proliferation inhibition in oxaliplatin-resistant colon cancer cells

(2021) Juhee Park et al.   ARCHIVES OF PHARMACAL RESEARCH

ROS in cancer therapy: the bright side of the moon

(2020) Bruno Perillo et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

The p38 MAPK Signaling Activation in Colorectal Cancer upon Therapeutic Treatments

(2020) Angelina Pranteda et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Alternative Options for Skin Cancer Therapy via Regulation of AKT and Related Signaling Pathways

(2020) Sun-Young Hwang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

CB13, a novel PPARγ ligand, overcomes radio-resistance via ROS generation and ER stress in human non-small cell lung cancer

(2020) Tae Woo Kim et al.   Cell Death & Disease

Echinatin effectively protects against NLRP3 inflammasome–driven diseases by targeting HSP90

(2020) Guang Xu et al.   JCI Insight

The synergistic effects of oxaliplatin and piperlongumine on colorectal cancer are mediated by oxidative stress

(2019) WeiQian Chen et al.   Cell Death & Disease

Retrochalcone Echinatin Triggers Apoptosis of Esophageal Squamous Cell Carcinoma via ROS- and ER Stress-Mediated Signaling Pathways

(2019) Ah-Won Kwak et al.   MOLECULES

Dual inhibition of EGFR and MET by Echinatin retards cell growth and induces apoptosis of lung cancer cells sensitive or resistant to gefitinib

(2019) Ha‐Na Oh et al.   PHYTOTHERAPY RESEARCH

Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis

(2018) Hsi-Hsien Hsu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Activation of apoptosis signalling pathways by reactive oxygen species

(2016) Maureen Redza-Dutordoir et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance

(2015) E. Martinez-Balibrea et al.   MOLECULAR CANCER THERAPEUTICS

p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents

(2013) Xinbing Sui et al.   CANCER LETTERS

Phosphorylation of P68 RNA Helicase by P38 MAP kinase contributes to colon cancer cells apoptosis induced by oxaliplatin

(2012) Heena Dey et al.   BMC CELL BIOLOGY

Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells

(2011) D Bose et al.   BRITISH JOURNAL OF CANCER

Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells

(2010) Huei-Fang Liu et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Platinum-DNA Interactions and Subsequent Cellular Processes Controlling Sensitivity to Anticancer Platinum Complexes

(2010) Saeed Ahmad   CHEMISTRY & BIODIVERSITY

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

(2009) Dunyaporn Trachootham et al.   NATURE REVIEWS DRUG DISCOVERY